Seroepidemiology of maternally-derived antibody against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda - PROGRESS GBS

Background: Group B Streptococcus (GBS) is a major contributor to the high burden of neonatal and young infant infectious disease in resource- limited settings. As disease protection during the first six months of life is provided via placental transfer of maternal antibodies, a maternal GBS vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyohere, Mary, Davies, Hannah Georgia, Musoke, Philippa, Nakimuli, Annettee, Tusubira, Valerie, Tasimwa, Hannington Baluku, Nsimire, Juliet Sendagala, Heath, Paul, Cose, Stephen, Baker, Carol, Le Doare, Kirsty, Sekikubo, Musa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706450/
https://www.ncbi.nlm.nih.gov/pubmed/33299966
http://dx.doi.org/10.12688/gatesopenres.13183.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706450/
https://www.ncbi.nlm.nih.gov/pubmed/33299966
http://dx.doi.org/10.12688/gatesopenres.13183.2

Ejemplares similares